Therapy Areas: Oncology
MaaT Pharma receives positive safety update for Phase 2b PHOEBUS trial of MaaT033
7 October 2025 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) announced on Tuesday that the independent Data Safety Monitoring Board (DSMB) has completed its second planned s...
Daiichi Sankyo and AstraZeneca report positive phase 3 results for DATROWAY in metastatic triple negative breast cancer
6 October 2025 - Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) and British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (Nasdaq:AZN) said on Monday that their t...
Polarean expands Ascend Imaging partnership to boost US market reach
6 October 2025 - Medical imaging technology company Polarean Imaging plc (AIM: POLX) announced on Monday that it has expanded its commercial agreement with Ascend Imaging LLC, extending coverage of it...
HanchorBio's HCB301 abstract accepted for poster presentation at SITC 2025 Annual Meeting
6 October 2025 - HanchorBio, a Taiwan-based, clinical-stage biotechnology company focused on immune-oncology and next-generation multi-specific immunotherapies, said on Friday that an abstract detaili...
XenoSTART and Minerva Imaging expand partnership
3 October 2025 - Cancer research organisation The START Center for Cancer Research, its preclinical division XenoSTART, and Denmark-based biotech company Minerva Imaging, announced on Tuesday an expan...
INOVIO announces inducement grant to new employee
3 October 2025 - INOVIO (NASDAQ:INO), a US-based biotechnology company focused on developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and i...